Humankind Investments’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,744
Closed -$1.65M 105
2025
Q3
$1.65M Sell
5,744
-212
-4% -$56.8K 0.38% 34
2025
Q2
$1.56M Buy
5,956
+147
+3% +$35.8K 0.38% 38
2025
Q1
$1.35M Sell
5,809
-286
-5% -$69.4K 0.35% 42
2024
Q4
$1.4M Buy
6,095
+115
+2% +$26.4K 0.35% 38
2024
Q3
$1.34M Sell
5,980
-195
-3% -$42.9K 0.48% 40
2024
Q2
$1.26M Buy
6,175
+2,845
+85% +$579K 0.33% 45
2024
Q1
$727K Buy
3,330
+174
+6% +$38.3K 0.19% 62
2023
Q4
$717K Buy
3,156
+7
+0.2% +$1.47K 0.21% 58
2023
Q3
$633K Sell
3,149
-1,103
-26% -$233K 0.26% 50
2023
Q2
$882K Sell
4,252
-1,175
-22% -$228K 0.34% 42
2023
Q1
$1.07M Sell
5,427
-651
-11% -$134K 0.44% 31
2022
Q4
$1.23M Buy
6,078
+525
+9% +$103K 0.53% 28
2022
Q3
$977K Buy
5,553
+884
+19% +$181K 0.47% 31
2022
Q2
$940K Buy
4,669
+164
+4% +$35K 0.45% 32
2022
Q1
$1.02M Buy
4,505
+448
+11% +$105K 0.42% 36
2021
Q4
$1.09M Buy
4,057
+680
+20% +$168K 1.38% 20
2021
Q3
$816K Buy
3,377
+154
+5% +$38.8K 1.24% 24
2021
Q2
$764K Buy
3,223
+840
+35% +$191K 1.36% 26
2021
Q1
$522K Buy
+2,383
New +$478K 1.6% 21

Other funds holding LH

Humankind Investments's LH Position: Q4 2025 in Review

Humankind Investments sold out of Labcorp (LH) in Q4 2025, closing a stake of 5,744 shares — an estimated $1.65M sold.

Humankind Investments first reported a position in LH in Q1 2021 and held it in 19 quarters. The position peaked at $1.65M in Q3 2025. 1,024 funds tracked by Wall St. Rank hold LH as of Q4 2025.

  • Humankind Investments reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
  • Humankind Investments sold 5,744 Labcorp shares in Q4 2025, an estimated $1.65M.
  • Humankind Investments first reported a position in Labcorp in Q1 2021 and held it in 19 quarters.
  • Humankind Investments's Labcorp position peaked at $1.65M in Q3 2025.
  • 1,024 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on Humankind Investments's 13F filing for Q4 2025, filed 17 Feb 2026.